EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolic Reprogramming of Microglia in Neuroinflammation and Depression

Qingru Wu, Jing Tian, Yan Gu, Xiaoying Bi, Hailing Zhang

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27093984 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Qingru Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Changhai Hospital, Naval Medical University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Microglia, Neuroinflammatory Diseases, Depression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 252 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai outstanding academic leaders plan, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a highly heterogeneous psychiatric disorder with its pathogenesis increasingly linked to dysregulated neuroinflammation. Microglia, as the resident immune cells of the central nervous system (CNS), play a pivotal role in the initiation and progression of the neuroinflammation and the pathophysiology of depression. These cells exhibit a dual role in pro- and anti-inflammatory processes, dynamically regulating immune responses through immunometabolic reprogramming in response to environmental cues. This review elaborates how metabolic remodeling in microglia, particularly within glucose, lipid, and amino acid pathways, drives their polarization toward a pro-inflammatory phenotype. This shift promotes depression pathogenesis via the release of inflammatory factors, disruption of synaptic plasticity, and mediation of neurotoxicity. We further discuss the impact of existing antidepressants on cellular metabolism and highlight the promise and challenges of targeting specific microglial metabolic pathways as a novel therapeutic strategy. This synthesis provides new insights into the immunometabolic mechanisms of depression and outlines directions for developing targeted treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaNeuroinflammatory DiseasesDepressionHumansMetabolic ReprogrammingAnimalsInflammation

Stichwörter der Autor:innen

depressionglutamateglycolysisimmunometabolismlipid metabolismmetabolic reprogrammingmicrogliamitochondrianeuroinflammation

Autor:innen und Institutionen

  • Department of Neurology, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
  • National Key Laboratory of Immunity and Inflammation, Institute of Immunology, Naval Medical University, Shanghai 200433, China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai outstanding academic leaders plan
  • China Postdoctoral Science Foundation
  • Basic Medical Research Program of Changhai Hospital

Zitieren

APA

Wu, Q., Tian, J., Gu, Y., Bi, X., & Zhang, H. (2026). Metabolic Reprogramming of Microglia in Neuroinflammation and Depression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27093984

Vancouver

Wu Q, Tian J, Gu Y, Bi X, Zhang H. Metabolic Reprogramming of Microglia in Neuroinflammation and Depression. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27093984

BibTeX
@article{Wu2026,
  author = {Wu, Qingru and Tian, Jing and Gu, Yan and Bi, Xiaoying and Zhang, Hailing},
  title = {Metabolic Reprogramming of Microglia in Neuroinflammation and Depression},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27093984}
}
Kostenlos starten →